DPH — Dechra Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Dechra Pharmaceuticals, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

	R2019 June 30th	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	80.3	227	118	121	74.4
Net Total Accounts Receivable
Net Total Receivables	104	97.3	119	142	170
Total Inventory
Prepaid Expenses
Total Current Assets	292	449	392	444	468
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	58.4	76.4	87	100	159
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,042	1,238	1,214	1,293	1,569
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	118	137	156	159	164
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	532	600	581	627	814
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	509	638	633	667	755
Total Liabilities & Shareholders' Equity	1,042	1,238	1,214	1,293	1,569
Total Common Shares Outstanding